Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Obrindatamab
Trade Name
Synonyms MGD009|MGD-009|MGD 009
Drug Descriptions

Obrindatamab (MGD009) is an activating bispecific molecule that binds to both B7-H3 (CD276) and CD3, therefore bringing the targeted B7-H3-expressing cells together with T-cells, resulting in cytotoxic immune response (J Clin Oncol., 34 (no. 15_suppl): abstract TPS3105).

DrugClasses CD276 Antibody 8 CD3 Antibody 74
CAS Registry Number 2069959-72-2
NCIT ID C136983


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Obrindatamab Obrindatamab 0 1
Obrindatamab + Retifanlimab Obrindatamab Retifanlimab 0 1

Additional content available in CKB BOOST